Shield Therapeutics plc (STX.L)

GBp 2.7

(-1.67%)

Net Debt Summary of Shield Therapeutics plc

  • Shield Therapeutics plc's latest annual net debt in 2023 was 4.93 Million GBP , up 50.78% from previous year.
  • Shield Therapeutics plc's latest quarterly net debt in 2024 Q2 was 9.39 Million GBP , down 0.0% from previous quarter.
  • Shield Therapeutics plc reported annual net debt of 3.27 Million GBP in 2022, up 127.39% from previous year.
  • Shield Therapeutics plc reported annual net debt of -11.96 Million GBP in 2021, down -310.75% from previous year.
  • Shield Therapeutics plc reported quarterly net debt of 4.93 Million GBP for 2023 FY, up 50.78% from previous quarter.
  • Shield Therapeutics plc reported quarterly net debt of -7.82 Million GBP for 2023 Q2, down 0.0% from previous quarter.

Annual Net Debt Chart of Shield Therapeutics plc (2023 - 2014)

Historical Annual Net Debt of Shield Therapeutics plc (2023 - 2014)

Year Net Debt Net Debt Growth
2023 4.93 Million GBP 50.78%
2022 3.27 Million GBP 127.39%
2021 -11.96 Million GBP -310.75%
2020 -2.91 Million GBP 29.34%
2019 -4.12 Million GBP 57.2%
2018 -9.62 Million GBP 27.6%
2017 -13.29 Million GBP 36.61%
2016 -20.97 Million GBP -2793.52%
2015 -725 Thousand GBP -109.09%
2014 7.97 Million GBP 0.0%

Peer Net Debt Comparison of Shield Therapeutics plc

Name Net Debt Net Debt Difference